Basis of FLT as a cell proliferation marker: Comparative uptake studies with [3H]thymidine and [3H]arabinothymidine, and cell-analysis in 22 asynchronously growing tumor cell lines

Nuclear Medicine and Biology

Volumn 29, Issue 3, 2002, Pages 281-287

  Toyohara, Jun ^a   Waki, Atsuo ^b   Takamatsu, Shinji ^b   Yonekura, Yoshiharu ^b   Magata, Yasuhiro ^c   Fujibayashi, Yasuhisa ^b  

^a Nihon Medi Physics Co Ltd   (Japan)

^b UNIVERSITY OF FUKUI   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

S phase fraction; methyl 3H FLT; Cell proliferation; Tumor cell line

Indexed keywords

3' FLUOROTHYMIDINE H 3; DNA; THYMIDINE H 3; THYMIDINE KINASE INHIBITOR; THYMINE ARABINOSIDE H 3; TRACER; UNCLASSIFIED DRUG;

ARTICLE; CANCER; CANCER CELL CULTURE; CANCER GROWTH; CELL CYCLE S PHASE; CELL FRACTIONATION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG UPTAKE; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; INCUBATION TIME; MITOCHONDRION; RADIOACTIVITY;

ANIMALS; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; HUMANS; MICE; RADIOPHARMACEUTICALS; THYMIDINE; THYMIDINE KINASE; TUMOR CELLS, CULTURED;

EID: 0036205096     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(02)00286-X     Document Type: Article

References (35)

1. The retinoblastoma protein pathway and the restriction point
2. Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells
3. 124I]iododeoxyuridine
4. In situ localization of mitochondrial DNA replication in intact mammalian cells
5. 2-[C-11]thymidine imaging of malignant brain tumors
6. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs
7. The cell cycle and the retinoblastoma protein family
8. Structural modifications at the 2′- and 3′- positions of some pyrimidine nucleosides as determinants of their interaction with the mouse erythrocyte nucleoside transporter
9. 18F]FLT vs. [H-3]thymidine in mammalian tumor cells
10. 18F]FLT for imaging of cellular proliferation in vivo
11. Thymidine kinases, the enzymes and their clinical usefulness
12. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells
13. Loss of the p16/MTS1 tumor suppressor gene causes E2F-mediated deregulation of essential enzymes of the DNA precursor metabolism
14. The role of p16 in the E2F-dependent thymidine kinase regulation
15. Cell-cycle regulators and cancer
16. Comparison of anti-human immunodeficiency virus activities, cellular transport, and plasma and intracellular pharmacokinatics of 3′-fluoro-3′-deoxythymidine and 3′-azido-3′-deoxythymidine
17. In vivo measurement of carbon -11 thymidine uptake in non-Hodgikin's lymphoma using positron emission tomography
18. Human thymidine kinase 1. Regulation in normal and malignant cells
19. Thymidine concentrations in serum and urine of different animal species and man
20. Can thymidine kinase levels in breast tumors predict disease recurrence?
21. Local re-utilization of thymidine in normal mouse tissues as measured with iododeoxyuridine
22. 18F]fluorothymidine predicts changes in cell proliferation
23. Uptake of labeled FLT correlates with thymidine kinase (TK1) activity in human tumor cells
24. D-type cyclins
25. Inhibitors of mammalian G1 cycline-dependent kinases
26. Meningiomas: Clinical implications of a high proliferative potential determined by bromodeoxyuridine labeling
27. Carbon-11-thymidine and FDG to measure therapy response
28. Imaging proliferation in vivo with [F-18] FLT and positron emission tomography
29. Iododeoxyuridine (IUDR) uptake and retention as a measure of tumor growth
30. 131I]iododeoxyuridine
31. Brain tumor imaging with PET and 2-[carbon-11]thymidine
32. 11C-thymidine activity in human head and neck tumours using positron emission tomography (PET)
33. The retinoblastoma protein and cell cycle control
34. Activity of the cytosolic isozyme of thymidine kinase in human primary lung tumors with reference to malignancy